Biotech · Private company
Glia, LLC
Track this companyFree. Adds Glia, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Pro-ocular™ Topical Gel 1%Phase 3 · Ocular Graft-versus-host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CLM2 topical gelPhase 2 · Contact Lens DiscomfortClinicalTrials.gov · fetched Nov 12, 2026
- GL101Phase 2 · Ocular Surface DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Pro-ocular™ topical gelPhase 2 · Chronic Ocular Graft-versus-host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host DiseasePHASE2_PHASE3 · UNKNOWN · started Apr 15, 2021ClinicalTrials.gov NCT04769648 · fetched Nov 12, 2026
- Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.PHASE2 · COMPLETED · started Oct 17, 2019ClinicalTrials.gov NCT03990051 · fetched Nov 12, 2026
- Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical GelPHASE2 · COMPLETED · started Jun 27, 2019ClinicalTrials.gov NCT03994406 · fetched Nov 12, 2026
- Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101PHASE2 · COMPLETED · started Jan 22, 2016ClinicalTrials.gov NCT02656394 · fetched Nov 12, 2026